Bottle
Latest Bristol-Myers Squibb Company Patents:
- METHODS OF TREATING CANCER WITH ANTIBODIES AGAINST TIM3
- Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2A protein (NKG2A)
- Substituted thienopyrroles as PAD4 inhibitors
- Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors
- Antibodies Binding to Human PAD4 and Uses Thereof
Description
FIG. 1 is a front perspective view of our new design of a bottle;
FIG. 2 is a rear elevational view thereof;
FIG. 3 is a right side elevational view thereof;
FIG. 4 is a left side elevational view thereof;
FIG. 5 is a top plan view thereof; and,
FIG. 6 is a bottom view thereof.
The broken line showing of a bottle cap is for illustrative purposes only and does not form part of the claimed design.
Referenced Cited
Patent History
Patent number: D336733
Type: Grant
Filed: Aug 27, 1991
Date of Patent: Jun 22, 1993
Assignee: Bristol-Myers Squibb Company (New York City, NY)
Inventor: Frederick B. Hadtke (New Providence, NJ)
Primary Examiner: Bernard Ansher
Assistant Examiner: Lucy Lieberman
Attorney: Anthony M. Santini
Application Number: 7/752,231
Type: Grant
Filed: Aug 27, 1991
Date of Patent: Jun 22, 1993
Assignee: Bristol-Myers Squibb Company (New York City, NY)
Inventor: Frederick B. Hadtke (New Providence, NJ)
Primary Examiner: Bernard Ansher
Assistant Examiner: Lucy Lieberman
Attorney: Anthony M. Santini
Application Number: 7/752,231
Classifications
Current U.S. Class:
D/9522;
D/9516;
D/9563